cyclosporine or tacrolimus
0468E7-408
Approved small_molecule completed
Quick answer
cyclosporine or tacrolimus for Graft Rejection is a Approved program (small_molecule) at Wyeth is now a wholly owned subsidiary of Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Wyeth is now a wholly owned subsidiary of Pfizer
- Indication
- Graft Rejection
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed